Tiwari et al. [88] demonstrated that impairment of translational inhibition proteins like CYFIP2 in early Alzheimer’s disease has led to an increase in serine 214 tau phosphorylation by the CAMKIIα kinase. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.